ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT03394404

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03394404
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03394404. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-08 (actual); primary completion 2021-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation
Acronym
PHENOTYPE-AF
Intervention (Device)
ECG-I mapping and PVI
Lead sponsor
Barts & The London NHS Trust (class: other)

Record details

Record id
cardio:ct-nct03394404
Content hash
72ebacae99323de1c59b908220c9d83ee34303d87036b7579606deda468b5575